Emma Green is a dedicated rare disease advocate, serving as a Trustee for CamRare and a champion for integrated patient and stakeholder engagement throughout the clinical development life-cycle, She has worked closely with patient communities within the UK, Europe and Middle-East. Currently, Emma is Managing Director at Akmazo Health Ltd., offering SME business and clinical development consultancy services, along with executive coaching. Her career within the biopharmaceutical industry spans over two decades, including senior roles at Silence Therapeutics, Cell Therapy Catapult, Prosensa Therapeutics and Pfizer. Throughout her career, Emma has made significant contributions to rare disease therapies, including advanced therapies.
Advanced Therapies: Navigating Challenges and Fostering Collaboration for Patient Access
Cell and gene therapies are changing the way we think about and treat rare diseases. We’ll ask “is there adequate service provision, staffing and infrastructure in place to deliver each and every gene therapy safely, effectively and efficiently?”